SPCS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.606000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.000600E-01
Normal-vs-Stage2
7.557600E-01
Normal-vs-Stage3
2.290200E-01
Normal-vs-Stage4
6.411400E-01
Stage1-vs-Stage2
5.309200E-01
Stage1-vs-Stage3
6.965000E-01
Stage1-vs-Stage4
2.229800E-01
Stage2-vs-Stage3
3.635400E-01
Stage2-vs-Stage4
3.283600E-01
Stage3-vs-Stage4
1.807830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.293400E-01
Normal-vs-AfricanAmerican
6.464000E-01
Normal-vs-Asian
1.822640E-01
Caucasian-vs-AfricanAmerican
1.926620E-01
Caucasian-vs-Asian
6.799800E-02
AfricanAmerican-vs-Asian
4.438300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.150200E-01
Normal-vs-Female
8.469000E-01
Male-vs-Female
4.275200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.362000E-01
Normal-vs-Age(41-60Yrs)
9.740400E-01
Normal-vs-Age(61-80Yrs)
6.994600E-01
Normal-vs-Age(81-100Yrs)
7.933600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.192590E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.716400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.989580E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.982430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.767600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.733400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.087600E-01
Normal-vs-Daily Drinker
3.500800E-01
Normal-vs-Weekly Drinker
2.726400E-01
Normal-vs-Occasional Drinker
7.562800E-01
Normal-vs-Social Drinker
8.783800E-01
Non Drinker-vs-Daily Drinker
7.094600E-01
Non Drinker-vs-Weekly Drinker
5.062600E-01
Non Drinker-vs-Occasional Drinker
7.402400E-02
Non Drinker-vs-Social Drinker
3.003200E-01
Daily Drinker-vs-Weekly Drinker
7.580400E-01
Daily Drinker-vs-Occasional Drinker
4.100000E-02
Daily Drinker-vs-Social Drinker
2.289000E-01
Weekly Drinker-vs-Occasional Drinker
5.129500E-02
Weekly Drinker-vs-Social Drinker
1.923610E-01
Occasional Drinker-vs-Social Drinker
4.212600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.833800E-02
Normal-vs-Grade 2
1.314280E-02
Normal-vs-Grade 3
6.462000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.657400E-01
Grade 1-vs-Grade 3
9.147000E-01
Grade 1-vs-Grade 4
8.833800E-02
Grade 2-vs-Grade 3
8.280000E-01
Grade 2-vs-Grade 4
1.314280E-02
Grade 3-vs-Grade 4
6.462000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.246800E-01
Normal-vs-NonDiabetic
6.516000E-01
Diabetic-vs-NonDiabetic
9.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.670600E-01
Normal-vs-NoPancreatitis
6.890000E-01
Pancreatitis-vs-NoPancreatitis
2.366600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.012200E-01
Normal-vs-N1
7.702800E-01
N0-vs-N1
9.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.968600E-01
Normal-vs-TP53-NonMutant
7.971000E-01
TP53-Mutant-vs-TP53-NonMutant
4.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
